Home NDC 50242-202 EVRYSDI
Product NDC 50242-202
11-digit product format 502420202
Labeler code 50242
Product ID 50242-202_db0ced2d-1b1a-4b2e-ba6a-5e3cbe0226ed
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Risdiplam
Dosage form TABLET
Route ORAL
Labeler Genentech, Inc.
Application NDA219285
Marketing category NDA
Marketing start 2025-02-11
Substance RISDIPLAM
Active strength 5 mg/1
Pharmacologic classes Increased Protein Synthesis [PE], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Survival of Motor Neuron 2 Splicing Modifier [EPC], Survival of Motor Neuron 2 Splicing Modifiers [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219285-001 EVRYSDI RISDIPLAM 5MG TABLET / ORAL RLD, RS 2025-02-11
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219285-001 M-270 2026-10-03
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 fd3edfee7708…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219285-001 EVRYSDI 5MG TABLET / ORAL RLD, RS 2025-02-11 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 47 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 c2088c7a36db…2026-09-14 22:38:34 2026-08 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 84e616aacf4f…2026-08-18 06:07:40 2026-07 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 12350273 2038-10-01 U-1943 2025-07-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N219285-001 12122789 2041-04-15 Drug substance, Drug product 2025-03-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 9586955 2033-02-08 Drug substance, Drug product 2025-03-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 9969754 2035-05-11 U-1943 Drug substance, Drug product 2025-03-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 11827646 2036-01-25 U-1943 2025-03-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N219285-001 11534444 2038-10-04 U-1943 2025-03-05 fd3edfee7708…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base EVRYSDI
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RISDIPLAM 5 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50242-202-01 EVRYSDI 1 in 1 CARTON TABLET 1 26 50242-202-01 EVRYSDI 30 in 1 BOTTLE, PLASTIC TABLET 30 26
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50242-202 EVRYSDI (RISDIPLAM) POWDER, FOR SOLUTION EVRYSDI (RISDIPLAM) TABLET [GENENTECH, INC.] 20 Current NDC, 2 package rows 20250322_eceb9a99-7191-4be5-87c3-0102707cf98e.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 50242-202-01 50242020201 1 BOTTLE, PLASTIC in 1 CARTON (50242-202-01) / 30 TABLET in 1 BOTTLE, PLASTIC 2025-02-11 No No Current